Abstract
Despite the efficacy of novel chemotherapeutic agents and radiation therapy, considerable developments are still necessary to improve the tolerance and reduce the toxicity in healthy cells of cancer patients. Dietary polyphenols have received increasing interest as an alternative approach, particularly in cancer treatment, as they display strong antioxidant properties and reduced toxicity profiles in normal cells. For decades, the Mediterranean diet but particularly olive oil has been linked with increased health benefits and has been associated with decreased risks in cardiovascular diseases and cancers. The minor constituents of olives are its phenolic compounds including oleuropein, tyrosol, hydroxytyrosol and homovanillic alcohol. These main phenolic compounds all possess antioxidant activity, with particular potency exhibited in hydroxytyrosol (HT). An imbalance of reactive oxygen species cause oxidative stress that can damage cells, and consequently lead to the formation of cancer or various diseases. Here, we provide evidence for the dietary antioxidant and polyphenolic compound hydroxytyrosol for its potential application as both a chemopreventive and anti-cancer agent for the treatment of haematological and solid malignancies.
Aberrant gene expression caused by histone acetylation has also been associated with cancer and represents a potentially useful therapeutic target for dietary compounds. The use of histone deacetylase inhibitors derived naturally from the diet, such as butyrate, dially disulphide and sulforaphane, in the inhibition of carcinogenesis has been supported by numerous studies. Similarly probiotics have been reported to have positive health effects. We describe the underlying mechanisms and discuss the possible limitations and benefits of using dietary antioxidants and chromatin modifying compounds as potential anti-cancer agents.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ADP:
-
Adenosine diphosphate
- ADR:
-
Adriamycin
- ARE:
-
Antioxidant response element
- DADS:
-
Dially disulfide
- DNA:
-
Deoxyribonucleic acid
- H2O2 :
-
Hydrogen peroxide
- HDAC:
-
Histone deacetylases
- HDACi:
-
Histone deacetylase inhibitor
- HT:
-
Hydroxytyrosol
- IEC:
-
Intestine epithelial
- Keap1:
-
Kelch-like ECH-associating protein 1
- LDL:
-
Low-density lipoprotein
- MUFA:
-
Monosaturated fatty acids
- NAD+:
-
Nicotinamide adenine dinucleotide
- NO∙:
-
Nitric oxide
- Nrf2:
-
Nuclear factor E2-related factor 2
- O2 · − :
-
Superoxide anion radical
- 1O2 :
-
Singlet oxygen
- · OH:
-
Hydroxyl radical
- –OH:
-
Hydroxyl group
- PUFA:
-
Polyunsaturated fatty acids
- RNS:
-
Reactive nitrogen species
- ROO:
-
Peroxyl radical
- RT-PCR:
-
Real time-polymerase chain reaction
- SAHA:
-
Suberoylanilide hydroxamic acid
- SCFA:
-
Short chain fatty acid
- SFN:
-
Sulforaphane
- SFN-CYS:
-
Sulforaphane-cysteine
- SFN-NAC:
-
Sulforaphane-N-acetylase
- Sfrp4:
-
Secreted fizzled-related protein 4
- Sir2:
-
Silent information regulator 2
- SIRT:
-
Sirtuin
- UV:
-
Ultra violet
References
Akilen R, Tsiami A, Devendra D, Robinson N (2012) Cinnamon in glycaemic control: systematic review and meta analysis. Clin Nutr 31:609–615
Alarcón De La Lastra C, Barranco MD, Motilva V, Herrerías JM (2001) Mediterranean diet and health: biological importance of olive oil. Curr Pharm Des 7:933–950
Aruoma OI (1994) Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol 32:671
Assam El-Osta, Karagiannis TC (2010) Histone deacetylase inhibitors in medicine. Transworld Research Network, Kerala
Berni Canani R, Di Costanzo M, Leone L, Bedogni G, Brambilla P, Cianfarani S, Nobili V, Pietrobelli A, Agostoni C (2011) Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev 24:198
Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769–784
Boskou D (1996) In: Boskou D (ed) Olive oil: chemistry and technology. AOCS, Champaign, IL
Cadenas E (1989) Biochemistry of oxygen toxicity. Annu Rev Biochem 58:79–110
Chen C, Kong A-NT (2005) Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends Pharmacol Sci 26:318–326
Cicerale S (2012) Antimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil. Curr Opin Biotechnol 23:129–135
Corona G, Deiana M, Incani A, Vauzour D, Dessi MA, Spencer JPE (2007) Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem Biophys Res Commun 362:606–611
Cress WD, Seto E (2000) Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 184:1–16
Dashwood RH, Myzak MC, Ho E (2006) Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 27:344–349
Davis PA, Yokoyama W (2011) Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food 14(9):884–889
De La Puerta R, Dominguez MEM, Ruiz-Gutierrez V, Flavill JA, Hoult JRS (2001) Effects of virgin olive oil phenolics on scavenging of reactive nitrogen species and upon nitrergic neurotransmission. Life Sci 69:1213–1222
Della Ragione F, Cucciolla V, Borriello A, Della Pietra V, Manna C, Galletti P, Zappia V (2000) Pyrrolidine dithiocarbamate induces apoptosis by a cytochrome c-dependent mechanism. Biochem Biophys Res Commun 268:942–946
Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5:981–989
Doll R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191
Dye D (2009) Compound in broccoli may help protect against asthma and other respiratory diseases. Life Extension 15:18
Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, O’connor T, Harada T, Yamamoto M (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci 59:169–177
Fabiani R, Bartolomeo AD, Rosignoli P, Servili M, Selvaggini R, Montedoro GF, Saverio CD, Morozzi G (2006) Virgin olive oil phenols inhibit proliferation of human promyelocytic leukemia cells (HL6O) by inducing apoptosis and differentiation. J Nutr 136:614–619
Fabiani R, Rosignoli P, de Bartolomeo A, Fuccelli R, Servili M, Morozzi G (2011) The production of hydrogen peroxide is not a common mechanism by which olive oil phenols induce apoptosis on HL60 cells. Food Chem 125:1249–1255
Fernández Arroyo S (2012) Application of nanoLC-ESI-TOF-MS for the metabolomic analysis of phenolic compounds from extra-virgin olive oil in treated colon-cancer cells. J Pharm Biomed Anal 63:128–134
Filomeni G, Aquilano K, Rotilio G, Ciriolo MR (2003) Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Res 63:5940–5949
Fitó M (2005) Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis 181:149–158
Fortes C, Garcia-Vilas JA, Quesada AR, Medina MA (2012) Evaluation of the anti-angiogenic potential of hydroxytyrosol and tyrosol, two bio-active phenolic compounds of extra virgin olive oil, in endothelial cell cultures. Food Chem 134:134–140
Fridovich I (1974) Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 41:35–97
Fridovich I (1986) Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 58:61–97
Gazzani G (2012) Functional foods and their expanding applications in the improvement of human health. Curr Opin Biotechnol 23:127–128
Ghafourifar P, Sen CK (2007) Mitochondrial nitric oxide synthase. Front Biosci-Landmark 12:1072–1078
Gibbs A, Schwartzman J, Deng V, Alumkal J (2009) Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Proc Natl Acad Sci U S A 106:16663–16668
Gill CIR, Boyd A, Mcdermott E, Mccann M, Servili M, Selvaggini R, Taticchi A, Esposto S, Montedoro G, Mcglynn H, Rowland I (2005) Potential anti-cancer effects of virgin olive oil phenols on colorectal carcinogenesis models in vitro. Int J Cancer 117:1–7
Gordon MH (2001) Antioxidant activity of hydroxytyrosol acetate compared with that of other olive oil polyphenols. J Agric Food Chem 49:2480–2485
Granados-Principal S (2010) Hydroxytyrosol: from laboratory investigations to future clinical trials. Nutr Rev 68:191–206
Granados-Principal S, Quiles JL, Ramirez-Tortosa C, Camacho-Corencia P, Sanchez-Rovira P, Vera-Ramirez L, Ramirez-Tortosa M (2011) Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours. Mol Nutr Food Res 55:S117–S126
Gulcin I (2012) Antioxidant activity of food constituents: an overview. Arch Toxicol 86:345–391
Halliwell B (1996) Antioxidants in human health and disease. Annu Rev Nutr 16:33–50
Halliwell B, Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1–85
Ho E, Clarke JD, Dashwood RH (2009) Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr 139:2393–2396
Incani A, Deiana M, Corona G, Vafeiadou K, Vauzour D, Dessì MA, Spencer JPE (2010) Involvement of ERK, Akt and JNK signalling in H2O2-induced cell injury and protection by hydroxytyrosol and its metabolite homovanillic alcohol. Mol Nutr Food Res 54:788–796
Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS, WU CW (2000) Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem 275:20436–20443
Keys A (1986) The diet and 15-year death rate in the seven countries study. Am J Epidemiol 124:903
Khymenets O (2011) Direct analysis of glucuronidated metabolites of main olive oil phenols in human urine after dietary consumption of virgin olive oil. Food Chem 126:306–314
Kleerebezem M, Vaughan EF (2009) Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 63:269–290
Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, Yamamoto M (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate for proteasomal degradation of Nrf2. Mol Cell Biol 24:7130–7139
Kumar M, Nagpal R, Verma V, Kumar A, Kaur N, Hemalatha R, Gautam SK, Singh B (2013) Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev 71:23–34
Kwak M-K, Kensler TW (2010) Targeting NRF2 signaling for cancer chemoprevention. Toxicol Appl Pharmacol 244:66–76
Kyrtopoulos SA, Xenakis A, Sotiroudis GT, Sotiroudis TG (2003) Chemopreventative potential of minor components of olive oil against cancer. Italian J Food Sci 15:169
Licciardi PV, Wong S-S, Tang ML, Karagiannis TC (2010) Epigenome targeting by probiotic metabolites. Gut Pathog 2:24–28
Malheiro R (2011) Cultivar effect on the phenolic composition and antioxidant potential of stoned table olives. Food Chem Toxicol 49:450–457
Manna C, Galletti P, Maisto G, Cucciolla V, D’angelo S, Zappia V (2000) Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco-2 cells. FEBS Lett 470:341–344
Manson MM (2003) Cancer prevention—the potential for diet to modulate molecular signalling. Trends Mol Med 9:11–18
Marks PA, Xu WS (2009) Histone deacetylase inhibitors: potential in cancer therapy. J Cell Biochem 107:600–608
Mateos R, Pereira-Caro G, Saha S, Cert R, Redondo-Horcajo M, Bravo L, Kroon PA (2011) Acetylation of hydroxytyrosol enhances its transport across differentiated Caco-2 cell monolayers. Food Chem 125:865–872
McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD (2004) Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem 279(30):31556–31567
Miller CP, Singh MM, Rivera-Del Valle N, Manton CA, Chandra J (2011) Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors. J Biomed Biotechnol 2011:514261
Myzak MC, Dashwood RH (2006) Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 7:443–452
Myzak MC, Karplus PA, Chung FL, Dashwood RH (2004) A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64:5767–5774
Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki K, Tsubura A (2001) Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis 22(6):891–897
Noureen N, Rashid H, Kalsoom S (2010) Identification of type-specific anticancer histone deacetylase inhibitors: road to success. Cancer Chemother Pharmacol 66:625–633
Omar SH (2010) Cardioprotective and neuroprotective roles of oleuropein in olive. Saudi Pharm J 18:111–121
Othman NB (2009) Antioxidant phenolic compounds loss during the fermentation of Chétoui olives. Food Chem 116:662–669
Park JH, Kim JW, Lee C-M, Kim YD, Chung SW, Jung ID, Noh KT, Park JW, Heo DR, Shin YK, Seo JK, Park Y-M (2012) Sulforaphane inhibits the Th2 immune response in ovalbumin-induced asthma. BMB Rep 45:311–316
Pledgie-Tracy A, Sobolewski MD, Davidson NE (2007) Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 6:1013–1021
Rafehi H (2012) Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis. Genes Nutr 7:343
Raghavan A, Shah ZA (2012) Sirtuins in neurodegenerative diseases: a biological-chemical perspective. Neurodegener Dis 9:1–10
Rajendran P, Williams DE, Ho E, Dashwood RH (2011) Metabolism as a key to histone deacetylase inhibition. Crit Rev Biochem Mol Biol 46:181–199
Ramprasath VR, Jones PJH (2010) Anti-atherogenic effects of resveratrol. Eur J Clin Nutr 64:660–668
Roberfroid M, Gibson GR, Hoyles L, Mccartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco M-J, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104(Suppl 2):S1–S63
Santini V, Gozzini A, Ferrari G (2007) Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr Drug Metab 8:383–393
Saunders LR, Verdin E (2007) Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 26:5489–5504
Schapira M (2011) Structural biology of human metal-dependent histone deacetylases. Handb Exp Pharmacol 206:225–240
Seidel C (2012) Chromatin-modifying agents in anti-cancer therapy. Biochimie 94:2264
Silva JP, Coutinho OP (2010) Free radicals in the regulation of damage and cell death—basic mechanisms and prevention. Drug Discov Ther 4:144–167
Simopoulos AP (2001) The Mediterranean diets: what is so special about the diet of Greece? The scientific evidence. J Nutr 131:3065S–3073S
Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux J-J, Blugeon S, Bridonneau C, Furet J-P, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105:16731–16736
Somoza JR, Skene RJ, Katz BA, Mol C, Ho JD, Jennings AJ, Luong C, Arvai A, Buggy JJ, Chi E, Tang J, Sang B-C, Verner E, Wynands R, Leahy EM, Dougan DR, Snell G, Navre M, Knuth MW, Swanson RV, Mcree DE, Tari LW (2004) Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure (London, England: 1993) 12:1325–1334
Song J-D, Lee SK, Kim KM, Park SE, Park S-J, Kim KH, Ahn SC, Park YC (2009) Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells. J Biochem Mol Toxicol 23:71
Spiegel S, Milstien S, Grant S (2012) Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy. Oncogene 31:537–551
Stark AH, Madar Z (2002) Olive oil as a functional food: epidemiology and nutritional approaches. Nutr Rev 60:170
Tho XP, Jiyoung L (2012) Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases. Nutrients 4:1868
Tome-Carneiro J, Gonzalvez M, Larrosa M, Yanez-Gascon MJ, Garcia-Almagro FJ, Ruiz-Ros JA, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC (2012) One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am J Cardiol 110:356–363
Trichopoulou A (2000) Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev 9:869
Trichopoulou A, Lagiou P (1997) Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle. Nutr Rev 55:383–389
Tsukamoto Y, Kato J, Ikeda H (1997) Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae. Nature 388:900–903
Tuck KL (2002) Major phenolic compounds in olive oil: metabolism and health effects. J Nutr Biochem 13:636
Venugopal R, Jaiswal AK (1998) Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 17:3145–3156
Visioli F, Bellosta S, Galli C (1998) Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci 62:541–546
Visioli F, Poli A, Galli C (2002) Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev 22:65–75
Wargovich MJ (1997) Experimental evidence for cancer preventive elements in foods. Cancer Lett 114:11
Warleta F, Quesada CS, Campos M, Allouche Y, Beltran G, Gaforio JJ (2011) Hydroxytyrosol protects against oxidative DNA damage in human breast cells. Nutrients 3:839–857
Weinstein IB (1991) Cancer prevention: recent progress and future opportunities. Cancer Res 51:5080s–5085s
Wojcik M, Burzynska-Pedziwiatr I, Wozniak LA (2010) A review of natural and synthetic antioxidants important for health and longevity. Curr Med Chem 17:3262–3288
Zhang Y, Talalay P, Cho C-G, Posner GH (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 89(6):2399–2403
Acknowledgements
The support of the Australian Institute of Nuclear Science and Engineering is acknowledged. TCK was the recipient of AINSE awards. TCK is a Future Fellow and Epigenomic Medicine Laboratory supported by the Australian Research Council. Also supported in part by the Victorian Government’s Operational Infrastructure Support Program.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mazarakis, N., Karagiannis, T.C. (2014). Dietary Antioxidants and Chromatin Modifying Compounds as Potential Anti-cancer Therapies. In: Maulik, N., Karagiannis, T. (eds) Molecular mechanisms and physiology of disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0706-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0706-9_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0705-2
Online ISBN: 978-1-4939-0706-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)